# DNUT (Krispy Kreme, Inc. Common Stock) Stock Analysis — 2026-11-06

> Krispy Kreme surged ~30-40% to $4.60 on a Q3 adjusted EPS beat ($0.06 vs $0.01 expected) and raised revenue guidance, but the headline masks a 12.4% YoY revenue decline to $328.8M, a $13.4M GAAP loss, and a -25.6% collapse in U.S. revenue. The EBITDA improvement (+13% ex-insurance to $35.3M in Q3, +...

- Verdict: **Sell**
- Price at analysis: $4.60
- 1Y price target: $3.25 (-29.4% implied)
- 3Y price target: $3.00 (-34.8% implied)
- Technicals: RSI 83, MACD bearish
- Source: https://stockquantai.com/research/dnut/2026-11-06

## Executive Summary

Krispy Kreme surged ~30-40% to $4.60 on a Q3 adjusted EPS beat ($0.06 vs $0.01 expected) and raised revenue guidance, but the headline masks a 12.4% YoY revenue decline to $328.8M, a $13.4M GAAP loss, and a -25.6% collapse in U.S. revenue. The EBITDA improvement (+13% ex-insurance to $35.3M in Q3, +43% in Q2 to $28.8M) is driven by refranchising the Western U.S. and Japan, store closures, and capex cuts — financial engineering that shrinks the revenue base while flattering margins and free cash flow (+$82M). With net debt of $843.1M vs $610.7M market cap, 2.2x debt-to-equity, negative revenue growth projected through 2027, and an RSI of 83.4 at 91.5% of the 52-week high, this is a classic sell-the-rip setup.

## Price Targets

| Horizon | Price | Implied Growth |
|---|---|---|
| 1 Year | $3.25 | -29.4% |
| 3 Year | $3.00 | -34.8% |

## Scenarios

| Scenario | 1Y Price | 3Y Price | Thesis |
|---|---|---|---|
| Hyper Bull | $7.50 | $10.00 | Refranchising completes cleanly, 100+ shops open on time, U.S. same-store returns to low-single-digit growth and EBITDA hits $180M+. GLP-1 fears prove overblown, leverage falls below 3x and multiple re-rates to 12x EV/EBITDA. Short squeeze forces sustained institutional buying. |
| Bull | $5.75 | $7.00 | Q3 beat marks inflection: royalties stabilize revenue at $1.35B+, EBITDA $150M+ with FCF positive for full year. International offsets U.S. softness and debt paydown restores confidence, lifting stock 25% as turnaround credibility builds. |
| Neutral | $4.50 | $4.80 | Margin gains offset revenue declines, business flatlines at $1.3B revenue and $145M EBITDA. Stock chops around $4-5 as bears cite leverage and GLP-1 while bulls cite FCF. No re-rating without organic growth proof. |
| Bear | $3.25 | $3.00 | Post-squeeze fade: revenue stays negative through 2027, U.S. -20%+ base effect and royalty growth insufficient. $843M debt at ~10x EV/EBITDA proves too heavy for shrinking concept, GAAP losses persist and stock retests $2.81 lows. |
| Hyper Bear | $1.80 | $1.20 | Turnaround fails: organic sales accelerate down mid-high single digits on GLP-1 and consumer pullback, franchisees pull back, EBITDA misses $140M guide. Liquidity crunch forces dilutive equity raise below $3, wiping out equity holders. |

## Key Metrics

- Market Cap: $610.72M
- P/E Ratio: N/A (negative GAAP EPS)
- P/S Ratio: ~0.47x (on $1.3B guide)
- Revenue: ~$1.30B FY26 guide ($328.8M Q3, -12.4% YoY)
- Net Income: -$515.8M TTM (-33.9% margin)
- EPS: $-0.08 GAAP / $0.06 adj (Q3)
- Dividend Yield: N/A
- Beta: N/A
- 52-Week High: $5.03
- 52-Week Low: $2.81
- Short Interest: N/A (elevated, squeeze rally)

## Micro Analysis

Core business is shrinking while profitability is optically improving via asset sales and refranchising. U.S. weakness, McDonald's exit, and GAAP losses outweigh royalty-margin gains.

- **Revenue decline masked by refranchising**: Q3 net revenue $328.8M down 12.4% YoY, Q2 $331.0M down 12.8%, Q1 $367M down 2.2%. U.S. revenue down 25.6% in Q3. FY2026 guidance $1.25-1.35B vs $1.52B last year — a ~15% shrink. Management attributes decline to refranchising Western U.S. and Japan and closing underperforming doors, but organic sales down mid-single-digits per Seeking Alpha.
- **No GAAP profitability, thin adjusted profits**: Q3 GAAP loss $13.4M (-$0.08/share), fourth straight quarterly loss in Q2. TTM net loss cited at $515.8M with -33.9% net margin and ~$100M loss in 2025. Adjusted net income sevenfold increase sounds strong but off tiny base to $0.06/share. Missed Wall Street expectations in 8 of 19 quarters since IPO.
- **Leverage remains dangerous despite improvement**: Net debt $843.1M down from refranchising proceeds and refinancing, but still 1.38x market cap ($610.72M) and debt-to-equity ~2.2x, nearly tripling since 2022. FY2026 EBITDA guide $140-150M implies EV ~$1.45B at ~10x EV/EBITDA for a declining-revenue consumer staple — expensive, not cheap.
- **Failed growth pillars: McDonald's and delivery**: End of McDonald's partnership and pruning of underperforming delivery doors removed scale. System-wide sales $485.3M in Q1 up only 0.7%. Turnaround now relies on 100+ franchise openings and Market Development royalties, unproven after chronic -78.8% 5-year return vs S&P +85.4% and -80% since IPO.
- **Cash flow boost is one-time in nature**: Free cash flow swung sharply higher, up $82M, driven by lower capex, asset sale proceeds, and working capital, not operating leverage. Refranchising converts owned sales to lower royalty streams, permanently lowering revenue quality while near-term cash looks better.

## Macro Analysis

Consumer staples discretionary under pressure from GLP-1 adoption, inflation, and value-seeking behavior. Donuts face secular health headwinds while leveraged turnarounds are penalized by higher-for-longer rates.

- **GLP-1 secular demand destruction**: Zacks notes 11% of U.S. adults (~28M) on GLP-1s, reducing sugary snack purchases ~10%. This is a direct multi-year headwind for Krispy Kreme's Original Glazed-centric model, with negative revenue growth projected through 2027.
- **Pressured low-end consumer and traffic**: Nation's Restaurant News and October 2026 consumer sell-off highlight household spending pressure, inflation and fuel costs cited on Q3 call. Discretionary sweet treats lose trips to value QSR; CAVA comparison shows DNUT down 8.6% YoY while better-positioned concepts grow.
- **Credit conditions punish levered micro-caps**: With $843M net debt and sub-$5 stock deterring institutions, refinancing risk remains. Sub-$10 price limits institutional ownership, increasing volatility (29M volume vs normal, 30%+ intraday range $3.54-$5.03).
- **Franchise expansion faces macro volatility**: Plan for 100+ franchise stores requires franchisee capital in uncertain macro. International and Market Development strength helps diversify, but U.S. (max revenue contributor) remains weakest link.

## Revenue Opportunities

- **Capital-light franchise royalties** (potential: medium): Refranchising Western U.S. and Japan shifts to high-margin royalties. If 100+ planned shops open and mature, Market Development segment profitability already improving could stabilize EBITDA at $140-150M without heavy capex.
- **International growth** (potential: medium): International segment (UK, Australia, Canada, Japan, Mexico) showed strength offsetting U.S. -25.6%. Expansion in 40+ countries offers whitespace where GLP-1 penetration is lower and sweet-treat culture growing.
- **E-commerce, delivery optimization and pricing** (potential: low): Pruning unprofitable delivery doors and focusing on profitable e-commerce/delivery plus price/mix could lift same-shop sales and restore U.S. productivity after closures.

## Headwinds

- **Structural revenue shrinkage** (severity: high): 12-13% quarterly declines, FY guide down ~$200M YoY, mid-single-digit organic declines, loss of McDonald's distribution. Royalty model cannot offset lost owned-store sales near-term.
- **Balance sheet and GAAP losses** (severity: high): $843M net debt, 2.2x D/E, $515.8M net loss, negative $64M FCF historically, thin margins. Any EBITDA miss re-levers balance sheet quickly.
- **GLP-1 and health trends** (severity: high): 28M U.S. users cutting sugar 10%, healthy eating secular shift directly hits donuts. Hard to innovate away from core glazed without brand dilution.
- **Parabolic technicals and squeeze unwind** (severity: medium): RSI 83.4 extremely overbought, +30.68% in one day on 29M volume, trading $4.60 vs Wall Street $4.17 Hold target and $5.03 52-week high. Mean-reversion risk extreme.

## Tailwinds

- **Margin expansion from refranchising** (strength: medium): Adjusted EBITDA +43% in Q2, +13% in Q3 ex-items despite revenue down. Lower capex and overhead improve cash conversion.
- **Raised guidance and beat momentum** (strength: medium): Q3 revenue $328.76M vs $311.41M expected (+4.03%), EPS $0.06 vs $0.01 (+200% surprise). Raised revenue guidance signals management confidence in turnaround.
- **Deleveraging progress** (strength: medium): Net debt down meaningfully via refranchising proceeds and refinancing, leverage ratios improving, FCF +$82M reduces near-term distress risk.

## Disclaimer

This report was generated by an AI model and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Always conduct your own research and consult a licensed financial advisor before making investment decisions.